Sandra Zeña-Ñañez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sandra Zeña-Ñañez has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Ichiro Peralta
School of Medicine, Universidad Nacional Federico Villarreal, Lima 15088, Peru
1 shared publication - Cristian Díaz-Vélez
Universidad Privada Antenor Orrego, Trujillo, Perú. a. Gastroenterólogo, Investigador independiente. b. Maestría en investigación clínica
1 shared publication - Jacqueline B. Puicón-Suárez
Sociedad Científica de Estudiantes de Medicina, Universidad Nacional Pedro Ruiz Gallo, Lambayeque 14013, Peru
1 shared publication - Mario J. Valladares-Garrido
Escuela de Medicina Humana, Universidad Señor de Sipán, Chiclayo, Peru
1 shared publication - Virgilio Efrain Failoc Rojas
Universidad San Ignacio de Loyola
1 shared publication
Latest Publications
- Open Access
COVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study
COVID-19 vaccines have achieved a significant reduction in mortality, yet objective estimates are needed in specific settings. We aimed to determine the effectiveness of COVID-19 vaccination at a referral hospital in Lambayeque, Peru. We conducted a retrospective cohort study from February to September 2021. We included hospitalized patients with COVID-19, whose data were stored in NotiWeb, a patient data system of the Peruvian Ministry of Health. We applied a propensity score-weighting method according to baseline characteristics of patients, and estimated hazard ratios (HR) using Cox regression models. Of 1553 participants, the average age was 55 years (SD: 16.8), 907 (58%) were male, and 592 (38%) deceased at 28-day follow-up. Before hospital admission, 74 (4.8%) had been immunized with at least one vaccine dose. Effectiveness against death in vaccinated patients was 50% at 90-day follow-up (weighted HR 0.50, 95% CI 0.28–0.89). Our results support the effectiveness of COVID-19 vaccination against death and provide information after early immunization in Peru.
Open AccessCOVID-19 Vaccine Effectiveness at a Referral Hospital in Northern Peru: A Retrospective Cohort Study
COVID-19 vaccines have achieved a significant reduction in mortality, yet objective estimates are needed in specific settings. We aimed to determine the effectiveness of COVID-19 vaccination at a referral hospital in Lambayeque, Peru. We conducted a retrospective cohort study from February to September 2021. We included hospitalized patients with COVID-19, whose data were stored in NotiWeb, a patient data system of the Peruvian Ministry of Health. We applied a propensity score-weighting method according to baseline characteristics of patients, and estimated hazard ratios (HR) using Cox regression models. Of 1553 participants, the average age was 55 years (SD: 16.8), 907 (58%) were male, and 592 (38%) deceased at 28-day follow-up. Before hospital admission, 74 (4.8%) had been immunized with at least one vaccine dose. Effectiveness against death in vaccinated patients was 50% at 90-day follow-up (weighted HR 0.50, 95% CI 0.28–0.89). Our results support the effectiveness of COVID-19 vaccination against death and provide information after early immunization in Peru.